Latest News for: antibes

Edit

Antibe Announces Appointment of Receiver

Business Wire 24 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Appointment of Receiver ... .
Edit

Antibe Provides Update on CCAA Proceedings

Business Wire 19 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Provides Update on CCAA Proceedings ... .
Edit

Antibe Announces TSX Delisting Review

Business Wire 16 Apr 2024
TORONTO--(BUSINESS WIRE)--Antibe Announces TSX Delisting Review ... .
Edit

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Business Wire 10 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Granting of Initial Order under Companies' Creditors Arrangement Act ... .
Edit

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Business Wire 09 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe to File an Application for an Initial Order under Companies' Creditors Arrangement Act ... .
Edit

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Business Wire 01 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE ANNOUNCES FDA CLINICAL HOLD ON OTENAPROXESUL AND LEGAL ACTION BY NUANCE ... .
Edit

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

Business Wire 20 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE ASRA PAIN MEDICINE MEETING ... .
Edit

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

Business Wire 07 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE AMERICAN ACADEMY OF PAIN MEDICINE MEETING ... .
Edit

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Business Wire 04 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma ... .
Edit

Antibe Therapeutics Shares Sink After Arbitration Case Lost

Market Watch 04 Mar 2024
Antibe Therapeutics' shares were down sharply after the biotechnology company lost a dispute in arbitration over a license agreement for the commercialization of its lead drug candidate in the Greater China region.

Most Viewed

File - In this image provided by the U.S. Army, U.S. Army Sgt. Ian Ketterling, gunner for Alpha Battery, 1st Battalion, 3rd Field Artillery Regiment, 17th Field Artillery Brigade, prepares the crane for loading the Army Tactical Missile System (ATACMS) on to the High Mobility Artillery Rocket System (HIMARS) in Queensland, Australia, July 26, 2023. U.S. officials say Ukraine for the first time has begun using long-range ballistic missiles, called ATACMS, striking a Russian military airfield in Crimea and Russian troops in another occupied area overnight.
AP / Sgt. 1st Class Andrew Dickson/U.S. Army via AP
EP Plenary session - 20th Anniversary of the 2004 EU Enlargement
© European Union 2024 - Source : EP / © European Union 2024 - Source : EP
Estonian Tax and Customs Board`s new Nuctech mobile Xray (36425971793)
Creative Commons / EU2017EE Estonian Presidency https://www.flickr.com/people/145047505@N06
Donald Trump
Jabin Botsford/The Washington Post via AP, Pool / The Washington Post
U.S. Secretary of State Antony Blinken, left, talks with Shanghai Party Secretary Chen Jining at the Grand Halls, Thursday, April 25, 2024, in Shanghai, China.
AP Photo/Mark Schiefelbein, Pool / Copyright 2024 The Associated Press. All rights reserved.
The ocean is the body of salt water which covers approximately 71% of the surface of the Earth, February 21, 2021.
Creative Commons / Unsplash/ Michal Matlon
Symposium Cisco Ecole Polytechnique 9-10 April 2018 Artificial Intelligence & Cybersecurity
Creative Commons / École polytechnique - J.Barande
×